Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens: Sub-analysis of the CheckMate 032 study Meeting Abstract


Authors: Patrick, O.; Emiliano, C.; Padmanee, S.; Dirk, J.; Paolo, A.; Ian, C.; Johanna, B.; Katriina, P.; Matthew, T.; Marina, T.; Cecile, D.; Yelena, J.; Dung, L.
Abstract Title: Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens: Sub-analysis of the CheckMate 032 study
Meeting Title: ESMO 19th World Congress on Gastrointestinal Cancer
Journal Title: Annals of Oncology
Volume: 28
Issue: Suppl. 3
Meeting Dates: 2017 Jun 28-Jul 1
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2017-06-01
Start Page: mdx262.006
Language: English
ACCESSION: WOS:000405528100370
PROVIDER: wos
DOI: 10.1093/annonc/mdx262.006
Notes: Meeting Abstract: O-007 -- Appears on page 139 of the abstract book -- Yelena Janjigian's first and last names are reversed on the original publication -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yelena Yuriy Janjigian
    401 Janjigian